LENALIDOMID Zentiva caps 2.5 mg 21 pce

7680678500014 CH-67850 L04AX04 07.16.4.

Active substances:

Reimbursement limitations:

EMETCHEMOTHE

Chimiothérapie fortement émétogène.

LENALIDOMID Zentiva caps 2.5 mg 21 pce
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6785001
CPT
-
Packaging group
21
Unit
Kapsel(n)
Composition
lenalidomidum 2.5 mg, cellulosum microcristallinum, lactosum 33.2 mg, carmellosum natricum conexum corresp. natrium 0.089 mg, magnesii stearas, Kapselhülle: gelatina, titanii dioxidum, E 172 (flavum), E 132, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula.

Articles (1)

Lenalidomid Zentiva 2.5 mg, Hartkapseln
Kapseln
21
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
21/08/2026
Professional SmPC
Français
21/08/2026
Professional SmPC
Italien
21/08/2026
Patient information leaflet
Allemand
22/02/2023
Patient information leaflet
Français
22/02/2023
Patient information leaflet
Italien
22/02/2023

Detailed composition

Substance Quantity Type Category
lenalidomidum
2.5 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
lactosum
33.2 MG Substance HBESI
carmellosum natricum conexum
- Substance HNIDK
natrium
0.089 MG Substance HBESI
magnesii stearas
- Substance HNIDK
gelatina
- Substance HNIDK
titanii dioxidum
- Substance HNIDK
E 172 (flavum)
- Substance FTODK
E 132
- Substance FIMDK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
kalii hydroxidum
- Substance HNIDK

Reimbursement information

Public price
CHF 766.00
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/03/2022

Authorization holder

Helvepharm AG

8500 Frauenfeld

Authorization information

Swissmedic authorization number
67850
Drug name
Lenalidomid Zentiva, Hartkapseln
Galenic form
KAHA
ATC Code
L04AX04
Authorization status
Z
Dispensation category
A
First authorization
29/10/2020
Authorization expiration date
31/12/9999
IT number
07.16.4.
Domain
Human medicine
Field of application
Onkologikum

Packaging details

Description (FR)
LENALIDOMID Zentiva caps 2.5 mg 21 pce
Description (DE)
LENALIDOMID Zentiva Kaps 2.5 mg 21 Stk
Market launch
29/10/2020
Narcotic (BTM)
No

Original drug

REVLIMID, Hartkapseln
CHF 2480.50
View original

Other packaging sizes

LENALIDOMID Zentiva caps 5 mg 21 pce
21 KAP
View
LENALIDOMID Zentiva caps 7.5 mg 21 pce
21 KAP
View
LENALIDOMID Zentiva caps 10 mg 21 pce
21 KAP
View
LENALIDOMID Zentiva caps 15 mg 21 pce
21 KAP
View
LENALIDOMID Zentiva caps 20 mg 21 pce
21 KAP
View
LENALIDOMID Zentiva caps 25 mg 21 pce
21 KAP
View
Buy us a coffee Explore the data